CF
SLN
Cantor Fitzgerald’s Silence Therapeutics SLN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.58M | Buy |
789,039
+15,194
| +2% | +$88.1K | 0.08% | 47 |
|
|
2025
Q1 | $2.18M | Buy |
773,845
+234,119
| +43% | +$660K | 0.05% | 61 |
|
|
2024
Q4 | $3.71M | Buy |
539,726
+205,534
| +62% | +$1.41M | 0.07% | 28 |
|
|
2024
Q3 | $6.08M | Buy |
334,192
+86,226
| +35% | +$1.57M | 0.17% | 15 |
|
|
2024
Q2 | $4.71M | Buy |
247,966
+144,483
| +140% | +$2.75M | 0.93% | 26 |
|
|
2024
Q1 | $2.24M | Sell |
103,483
-43,294
| -29% | -$935K | 0.53% | 31 |
|
|
2023
Q4 | $2.55M | Sell |
146,777
-21,416
| -13% | -$372K | 0.52% | 34 |
|
|
2023
Q3 | $1.65M | Sell |
168,193
-125,700
| -43% | -$1.23M | 0.04% | 234 |
|
|
2023
Q2 | $1.62M | Buy |
293,893
+4,735
| +2% | +$26K | 0.04% | 270 |
|
|
2023
Q1 | $1.79M | Sell |
289,158
-12,532
| -4% | -$77.7K | 0.04% | 321 |
|
|
2022
Q4 | $4.6M | Buy |
301,690
+91,804
| +44% | +$1.4M | 0.1% | 251 |
|
|
2022
Q3 | $2.11M | Sell |
209,886
-1,574
| -0.7% | -$15.8K | 0.05% | 334 |
|
|
2022
Q2 | $2.51M | Buy |
211,460
+37,735
| +22% | +$447K | 0.05% | 334 |
|
|
2022
Q1 | $3.3M | Sell |
173,725
-80,794
| -32% | -$1.54M | 0.25% | 104 |
|
|
2021
Q4 | $6.08M | Buy |
+254,519
| New | +$6.08M | 0.43% | 52 |
|